Literature DB >> 9635851

Treatment-induced mucositis: an old problem with new remedies.

R P Symonds1.   

Abstract

Mucositis may be a painful, debilitating, dose-limiting side-effect of both chemotherapy and radiotherapy for which there is no widely accepted prophylaxis or effective treatment. The basis of management is pain relief, prevention of dehydration and adequate nutrition. When tested vigorously, most antiseptic mouthwashes and anti-ulcer agents are ineffective. Simple mechanical cleansing by saline is the most effective traditional measure. A variety of new agents are effective. Granulocyte macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) act outwith the haemopoeitic system and can reduce mucositis, but the best schedule, dosage and method of administration is not known or which is the best growth factor to prevent this side-effect. A placebo-controlled randomized trial of antibiotic pastilles has shown a significant reduction in mucositis and weight loss during radiotherapy for head and neck cancer. Another method to reduce radiation effects in normal tissue is to stimulate cells to divide before radiotherapy by silver nitrate or interleukin 1. These methods may be particularly effective when given along with hyperfractionated radiation treatment such as CHART.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635851      PMCID: PMC2150071          DOI: 10.1038/bjc.1998.279

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  60 in total

1.  Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy.

Authors:  N J Meropol; L L Miller; E L Korn; L E Braitman; M L MacDermott; L M Schuchter
Journal:  J Natl Cancer Inst       Date:  1992-08-05       Impact factor: 13.506

Review 2.  The oral complications of specific anticancer therapy.

Authors:  S Holmes
Journal:  Int J Nurs Stud       Date:  1991       Impact factor: 5.837

3.  Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.

Authors:  J T Johnson; G A Ferretti; W J Nethery; I H Valdez; P C Fox; D Ng; C C Muscoplat; S C Gallagher
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

4.  Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial.

Authors:  R Pettengell; H Gurney; J A Radford; D P Deakin; R James; P M Wilkinson; K Kane; J Bentley; D Crowther
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

5.  A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients.

Authors:  S B Woo; S T Sonis; M M Monopoli; A L Sonis
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

6.  Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation.

Authors:  J B Epstein; L Vickars; J Spinelli; D Reece
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1992-06

7.  A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis.

Authors:  L K Rocke; C L Loprinzi; J K Lee; S J Kunselman; R K Iverson; G Finck; D Lifsey; K C Glaw; B A Stevens; A K Hatfield
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

8.  Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy.

Authors:  A Berger; M Henderson; W Nadoolman; V Duffy; D Cooper; L Saberski; L Bartoshuk
Journal:  J Pain Symptom Manage       Date:  1995-04       Impact factor: 3.612

9.  A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.

Authors:  F G LeVeque; M Montgomery; D Potter; M B Zimmer; J W Rieke; B W Steiger; S C Gallagher; C C Muscoplat
Journal:  J Clin Oncol       Date:  1993-06       Impact factor: 44.544

10.  High dose, dose-intensive chemotherapy with doxorubicin and cyclophosphamide for the treatment of advanced breast cancer.

Authors:  J E Ferguson; D J Dodwell; A M Seymour; M A Richards; A Howell
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

View more
  13 in total

Review 1.  Interventions for preventing oral mucositis for patients with cancer receiving treatment.

Authors:  Helen V Worthington; Jan E Clarkson; Gemma Bryan; Susan Furness; Anne-Marie Glenny; Anne Littlewood; Martin G McCabe; Stefan Meyer; Tasneem Khalid
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 2.  The cancer patient with severe mucositis.

Authors:  W Carl; J Havens
Journal:  Curr Rev Pain       Date:  2000

Review 3.  Interventions for treating oral mucositis for patients with cancer receiving treatment.

Authors:  Jan E Clarkson; Helen V Worthington; Susan Furness; Martin McCabe; Tasneem Khalid; Stefan Meyer
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

Review 4.  Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer.

Authors:  K Hoekman; W J van der Vijgh; J B Vermorken
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

5.  Amino Acids May Have Protective Effects on Salivary Glands of 5-FU-administered Mice.

Authors:  Rieko Fujiwara; Koji Harada; Tarannum Ferdous; Katsuaki Mishima
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

6.  5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells.

Authors:  M Yasuda; S Kato; N Yamanaka; M Iimori; K Matsumoto; D Utsumi; Y Kitahara; K Amagase; S Horie; K Takeuchi
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

7.  Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis.

Authors:  B A Carneiro-Filho; I P F Lima; D H Araujo; M C Cavalcante; G H P Carvalho; G A C Brito; V Lima; S M N Monteiro; F N Santos; R A Ribeiro; A A M Lima
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

8.  Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.

Authors:  Shinichi Kato; Shusaku Hayashi; Yumeno Kitahara; Koyo Nagasawa; Hitomi Aono; Junichiro Shibata; Daichi Utsumi; Kikuko Amagase; Makoto Kadowaki
Journal:  PLoS One       Date:  2015-01-07       Impact factor: 3.240

9.  Oral Administration of Surface-Deacetylated Chitin Nanofibers and Chitosan Inhibit 5-Fluorouracil-Induced Intestinal Mucositis in Mice.

Authors:  Ryo Koizumi; Kazuo Azuma; Hironori Izawa; Minoru Morimoto; Kosuke Ochi; Takeshi Tsuka; Tomohiro Imagawa; Tomohiro Osaki; Norihiko Ito; Yoshiharu Okamoto; Hiroyuki Saimoto; Shinsuke Ifuku
Journal:  Int J Mol Sci       Date:  2017-01-27       Impact factor: 5.923

10.  Protective potentials of Annona muricata fruit pulp on etoposide-induced gastrointestinal toxicity in Wistar rats.

Authors:  Shyamala Nayak; Gayathri M Rao; Aradhana Marathe; M Vyshnavi
Journal:  J Carcinog       Date:  2019-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.